What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion.
| Author | |
|---|---|
| Abstract | :
Lisdexamfetamine dimesylate (LDX) is a prodrug approved for attention deficit/hyperactivity disorder and for moderate-to-severe binge eating disorder in adults in some countries. |
| Year of Publication | :
2022
|
| Journal | :
Expert review of clinical pharmacology
|
| Volume | :
15
|
| Issue | :
8
|
| Number of Pages | :
921-925
|
| ISSN Number | :
1751-2433
|
| URL | :
https://www.tandfonline.com/doi/full/10.1080/17512433.2022.2112950
|
| DOI | :
10.1080/17512433.2022.2112950
|
| Short Title | :
Expert Rev Clin Pharmacol
|
| Download citation |